A M El-Hassan
Overview
Explore the profile of A M El-Hassan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1405
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Musa A, Khalil E, Younis B, Elfaki M, Elamin M, Adam A, et al.
J Trop Med
. 2013 May;
2013:708391.
PMID: 23690794
Unlabelled: Post-kala-azar dermal leishmaniasis (PKDL) is a dermatosis that affects more than 50% of successfully treated visceral leishmaniasis (VL) patients in Sudan. PKDL is considered an important reservoir for the...
2.
Fahal A, Rahman I, El-Hassan A, Rahman M, Zijlstra E
Trans R Soc Trop Med Hyg
. 2011 Jan;
105(3):127-32.
PMID: 21247608
This prospective study aimed to determine the safety and efficacy of itraconazole for the treatment of patients with mycetoma due to Madurella mycetomatis. The study consisted of 13 patients with...
3.
Elnojomi N, Musa A, Younis B, Elfaki M, El-Hassan A, Khalil E
Saudi J Kidney Dis Transpl
. 2010 Sep;
21(5):872-5.
PMID: 20814123
Sudanese visceral leishmaniasis (VL) is a disease of children that is characterized by fever, hepatosplenomegaly, lymphadenopathy, pancytopenia, and renal injury. Microalbuminuria (MA) and urinary retinol binding protein (urRBP) are useful...
4.
Hamad S, Khalil E, Musa A, Ibrahim M, Younis B, Elfaki M, et al.
Exp Parasitol
. 2010 Mar;
125(4):389-93.
PMID: 20346944
Drug unresponsiveness in patients with visceral leishmaniasis (VL) is a problem in many endemic areas. This study aimed to determine genetic diversity of Leishmania donovani isolates from a VL endemic...
5.
Khalil E, Musa A, Elgawi S, Meshasha A, Gamar Eldawla I, Elhassan M, et al.
Ann Trop Med Parasitol
. 2008 Jan;
102(1):79-80.
PMID: 18186981
No abstract available.
6.
Sharafeldin G, Khalil E, El Hag I, Elsiddig K, Elsafi M, Aijafari A, et al.
East Afr Med J
. 2007 Jul;
84(1):3-7.
PMID: 17633578
Objective: To determine whether Mycobacterium tuberculosis infection spreads through the blood to different lymph-node groups in patients with tuberculous lymphadenitis. Design: Prospective analytical study. Setting: The patients were recruited, managed...
7.
Kordofani Y, Nour Y, El-Hassan A, Shalayel M
East Mediterr Health J
. 2004 Aug;
7(6):1061-4.
PMID: 15332749
Post kala azar dermal leishmaniasis (PKDL) is a condition that develops after treatment of kala azar. We report on 42 patients with suspected PKDL, 40% of whom were children. Diagnosis...
8.
Kamil A, Khalil E, Musa A, Modabber F, Mukhtar M, Ibrahim M, et al.
Trans R Soc Trop Med Hyg
. 2004 Jul;
97(3):365-8.
PMID: 15228261
In a previous efficacy study, autoclaved Leishmania major (ALM) + bacille Calmette-Guérrin (BCG) vaccine was shown to be safe, but not superior to BCG alone, in protecting against visceral leishmaniasis....
9.
Elsiddig K, Khalil E, Elhag I, Elsafi M, Suleiman G, Elkhidir I, et al.
Int J Tuberc Lung Dis
. 2003 May;
7(4):365-9.
PMID: 12729342
Objective: To determine the aetiological types of granulomatous disease of the breast in women presenting with mammary complaints in the Sudan. Methods: Clinical history and physical examination, complete blood counts,...
10.
Zijlstra E, Musa A, Khalil E, el-Hassan I, El-Hassan A
Lancet Infect Dis
. 2003 Feb;
3(2):87-98.
PMID: 12560194
Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL); it is characterised by a macular, maculopapular, and nodular rash in a patient who has recovered from VL and...